Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1987 2
1988 5
1989 5
1990 3
1991 6
1992 6
1994 2
1995 1
1996 1
1998 1
1999 4
2000 2
2001 3
2002 2
2003 1
2004 2
2005 1
2006 3
2007 2
2008 6
2009 15
2010 11
2011 15
2012 28
2013 39
2014 28
2015 23
2016 30
2017 36
2018 40
2019 39
2020 57
2021 58
2022 69
2023 61
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

561 results

Results by year

Filters applied: . Clear all
Page 1
Bmal1 integrates mitochondrial metabolism and macrophage activation.
Alexander RK, Liou YH, Knudsen NH, Starost KA, Xu C, Hyde AL, Liu S, Jacobi D, Liao NS, Lee CH. Alexander RK, et al. Among authors: liao ns. Elife. 2020 May 12;9:e54090. doi: 10.7554/eLife.54090. Elife. 2020. PMID: 32396064 Free PMC article.
Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients With Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia: The PEONY Phase 3 Randomized Clinical Trial.
Shao Z, Pang D, Yang H, Li W, Wang S, Cui S, Liao N, Wang Y, Wang C, Chang YC, Wang H, Kang SY, Seo JH, Shen K, Laohawiriyakamol S, Jiang Z, Li J, Zhou J, Althaus B, Mao Y, Eng-Wong J. Shao Z, et al. Among authors: liao n. JAMA Oncol. 2020 Mar 1;6(3):e193692. doi: 10.1001/jamaoncol.2019.3692. Epub 2020 Mar 12. JAMA Oncol. 2020. PMID: 31647503 Free PMC article. Clinical Trial.
Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancer.
Li JY, Jing R, Wei H, Wang M, Xiaowei Q, Liu H, Jian L, Ou JH, Jiang WH, Tian FG, Sheng Y, Li HY, Xu H, Zhang RS, Guan AH, Liu K, Jiang HC, Ren Y, He JJ, Huang W, Liao N, Cai X, Ming J, Ling R, Xu Y, Hu CY, Zhang J, Guo B, Ouyang L, Shuai P, Liu Z, Zhong L, Zeng Z, Zhang T, Xuan Z, Tan X, Liang J, Pan Q, Chen L, Zhang F, Fan LJ, Zhang Y, Yang X, BoLi J, Chen C, Jiang J. Li JY, et al. Among authors: liao n. Int J Cancer. 2019 Jan 15;144(2):281-289. doi: 10.1002/ijc.31601. Epub 2018 Nov 8. Int J Cancer. 2019. PMID: 29752822 Free article.
MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2- advanced breast cancer: the multinational randomized phase III study.
Zhang QY, Sun T, Yin YM, Li HP, Yan M, Tong ZS, Oppermann CP, Liu YP, Costa R, Li M, Cheng Y, Ouyang QC, Chen X, Liao N, Wu XH, Wang XJ, Feng JF, Hegg R, Kanakasetty GB, Coccia-Portugal MA, Han RB, Lu Y, Chi HD, Jiang ZF, Hu XC. Zhang QY, et al. Among authors: liao n. Ther Adv Med Oncol. 2020 Oct 22;12:1758835920963925. doi: 10.1177/1758835920963925. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 33149768 Free PMC article.
Effective methods of clinical education.
Liao N, Scherzer R, Kim EH. Liao N, et al. Ann Allergy Asthma Immunol. 2022 Mar;128(3):240-247. doi: 10.1016/j.anai.2021.11.021. Epub 2021 Dec 2. Ann Allergy Asthma Immunol. 2022. PMID: 34864188 Review.
Benefits of different intensities of pulmonary rehabilitation for patients with moderate-to-severe COPD according to the GOLD stage: a prospective, multicenter, single-blinded, randomized, controlled trial.
He GX, Li N, Ren L, Shen HH, Liao N, Wen JJ, Xu YM, Wang J, Li QY. He GX, et al. Among authors: liao n. Int J Chron Obstruct Pulmon Dis. 2019 Oct 8;14:2291-2304. doi: 10.2147/COPD.S214836. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 31631999 Free PMC article. Clinical Trial.
561 results